-
Did you mean
- link since
- lia) science
-
Rat Plasminogen ELISACatalog #: 41-PLART-E01
Sensitivity: 3.125 ng/mL
Range: 3.125-200 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Mouse Cystatin C ELISA
Catalog #: 41-CYCMS-E01
Sensitivity: 1.25 ng/mL
Range: 1.25-40 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Equine Haptoglobin ELISA
Catalog #: 41-HAPEQ-E01
Sensitivity: 18.75 ng/mL
Range: 18.75-600 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Endostatin ELISA
Catalog #: 04-BI-20742
Sensitivity: 0.2 nmol/l
Range: 0 - 80 nmol/L
Sample Types: Citrate Plasma, EDTA Plasma, Heparin Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Equine Hemoglobin ELISA
Catalog #: 41-HEMEQ-E01
Sensitivity: 6.25 ng/mL
Range: 6.25-400 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Rat Hemoglobin ELISA Plasma / Serum
Catalog #: 41-HEMRT-E01
Sensitivity: 6.25 ng/mL
Range: 6.25-200 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Mouse Hemopexin ELISA
Catalog #: 41-HMPMS-E01
Sensitivity: 12.5 ng/mL
Range: 12.5 - 400 ng/mL
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Rat Hemopexin ELISA
Catalog #: 41-HMPRT-E01
Sensitivity: 6.25 ng/mL
Range: 6.25 - 400 ng/mL
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Alpha 1-Acid Glycoprotein ELISA
Catalog #: 41-AGPHU-E01
Sensitivity: 5 ng/mL
Range: 5-320 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Canine Complement Factor 3 ELISA
Catalog #: 41-CO3CA-E01
Sensitivity: 6.25 ng/mL
Range: 6.25-200 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Anti-Jo-1 ELISA
Catalog #: 35-JO1HU-E01
Sensitivity: 2.9 U/mL
Range: 3 - 300 U/mL
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Chicken Alpha 1-Acid Glycoprotein ELISA
Catalog #: 41-AGPCH-E01
Sensitivity: 6.25 ng/mL
Range: 6.25-200 ng/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric
Alpco Home Page
New: Calprotectin Immunoturbidimetric Assay will take your testing to the next level. Learn more.Supporting your work with life science and clinical testing productsVIEW ALL LIFE SCIENCE PRODUCTSVIEW ALL CLINICAL DIAGNOSTIC PRODUCTS
Tips & Tricks
The Enzyme-Linked Immunosorbent Assay (ELISA) is a proven sensitive method for detecting and quantifying specific biomarkers in a wide range of clinical and research samples. The accuracy and precision of ELISAs can be affected by many factors, including pipetting, washing, and sample-handling techn...
Company Overview
Accuracy and Efficiency. Together.We are a leading global developer and provider of innovative molecular and immunodiagnostic products focused on Infectious and Gastroenterological Diseases. We are a trusted partner creating value for research and clinical laboratories with high-quality, user-frien...
Responsibility
ALPCO’s Diabetes Research Travel GrantALPCO strives to provide scientists and healthcare professionals with robust tools for their research and clinical diagnostic endeavors. We understand that championing extraordinary discoveries requires extraordinary efforts, and support. We are proud to continu...
Understanding the Role of Energy Homeostasis in Diabetes
Introduction
The prevalence of diabetes and obesity has been on the rise for several decades and research has demonstrated that other parts of the body, including the cardiovascular system and kidneys, can be affected by diabetes. The key to understanding the relationship between diabetes and the...
PI3K Delta Signaling in Rheumatoid Arthritis
Date: September 6, 2016
Author: Andrea Tarbet, Product Marketing Associate at ALPCO
Signaling pathways dictate the differentiation, activation, and functions of immune cells. Even the slightest problem in one cell signaling pathway can transform the immune system and turn it against the body,...
Insulin Resistance: Root Causes, Detection, and Prevention
The Diabetes Pandemic
According to the U.S. Centers for Disease Control (CDC) and the World Health Organization, more than 34 million Americans and 422 million people worldwide have diabetes.1,2 90 to 95% of people with diabetes have type 2.1 The National Institute of Diabetes and Digestive and K...
Featured Biomarkers from A to Z
This handout briefly describes the role of several important hormones measured in research.
ALPCO-GeneProof Appoints Erik M. Allen as Chief Executive Officer
SALEM, N.H. and BRNO, Czech Republic, March 30, 2023 /PRNewswire/ -- American Laboratory Products Company, Ltd. ("ALPCO", or the "Company"), a global provider of specialty diagnostic solutions, today announced the appointment of Erik M. Allen as Chief Executive Officer (CEO). Mr....
Differentiating Gastrointestinal Pathogens from IBD and IBS
Gastrointestinal (GI) disorders such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), as well as infections from GI pathogens can present very similar symptoms. A host of tests have been developed to aid in the differentiation between IBD and IBS, such as calprotectin and lact...
Heart Disease Biomarkers in Diabetes Research
Introduction
Cardiovascular disease (CVD) encompasses a constellation of diseases related to the heart and circulatory system. Despite efforts to understand and combat CVD complications from diabetes, 65% of diabetics will pass away from cardiovascular issues1. Part 2 of The Common Denominator eBoo...
The Changing Roles of Bone Remodeling Biomarkers
Introduction
Bones are traditionally known for their support, protection and movement properties, as well as their role in the processes of mineral balance and blood cell production. Research supports that bones do more than they were originally recognized for. Previous research investigating osteo...
BTK Inhibitors as Cancer Drug Treatments
Date: July 26, 2016
Author: Andrea Tarbet, Product Marketing Associate at ALPCO
Over the past several years, the drug arsenal to combat B cell cancers has gained a mighty weapon: Bruton’s tyrosine kinase (BTK) inhibitors. The origins of using BTK inhibitors as cancer drug treatments actually b...
Class IA PI3K Inhibitor Cancer Therapies
Date: August 16, 2016
Author: Andrea Tarbet, Product Marketing Associate at ALPCO
Bruton’s tyrosine kinase (BTK) inhibitors are not the only kinase inhibitors to enter the fight against B cell cancers. Since there are numerous subtypes of Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), p...
Regulating Endocrine Disrupting Chemicals in Consumer Products
Date: September 27, 2016
Author: Andrea Tarbet, Product Marketing Associate at ALPCO
From cosmetics to water bottles, endocrine disrupting chemicals (EDCs) have surfaced in our everyday lives. EDCs are compounds that can interfere with the endocrine system’s ability to help an organism develop...
Endocrine Disrupting Chemicals and Biomarkers
Introduction
Humans and the environment are exposed to numerous chemicals every day1. Each year, about 2,000 new chemicals are manufactured in the U.S.2. Research findings over the years have shown how some chemicals known as endocrine disrupting chemicals (EDCs) can interact with the endocrine sys...
Emerging Biomarker Research in NAFLD and NASH
Nonalcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease in the western hemisphere affecting 1 in 3 adults and 1 in 10 children1. Today, liver biopsies are the only gold standard for precise diagnosis of NAFLD2. Because of this, there are tremendous efforts on the ...
Obesity Induced Adipose Tissue Dysfunction and NAFLD
Obesity is a known risk factor for developing metabolic diseases such as non-alcoholic fatty liver disease (NAFLD)1. An increasing amount of evidence shows that obesity induced adipose tissue dysfunction and NAFLD development are closely related2. Obesity induced changes to adipokine secretion can h...
Researching the Role of Gut Permeability in NAFLD
[playlist images="false" artists="false" tracklist="false" ids="4600"]
A growing amount of research demonstrates that communication between the gut microbiota and liver is vital for the regulation of energy metabolism1,2. As a result, scientists are further...
Dorothy Hodgkin’s Discovery of Insulin's 3D Structure
Nobel Prize winning British chemist Dr. Dorothy Hodgkin significantly contributed to unraveling the secrets of diabetes mellitus. She is considered a founder of X-ray crystallography, a technique used to discern the structures of organic biomolecules. Dorothy Hodgkin’s discovery of insulin's 3D...
How to Properly Collect and Handle GLP-1 Samples
We know that the proper collection and handling of samples is vital for accurately measuring GLP-1.
ALPCO is here to help your lab reduce technical errors and improve assay results when running the STELLUX® Chemi Active GLP-1 (7-36) amide ELISA.
Watch our video to learn how to properly collect...
A Guide to STELLUX® Chemiluminscence ELISAs: An Infographic
Today, multiple immunoassay platforms exist, providing scientists and clinicians with the means to measure a variety of biomarkers1,2,3. However, research indicates some immunoassay platforms have limitations that can inhibit progress in the laboratory4,5,6. In an effort to provide researchers with ...
A Comparison of Colorimetric and Chemiluminescence ELISAs
Are you curious about chemiluminescence ELISAs, but not exactly sure what they are, or how to use them? Our video A Comparison of Colorimetric and Chemiluminescence ELISAs discusses how similar these two types of assays are, and how they can enhance your lab testing.
Watch our video to:
Lear...
Now Available: 510(k) Cleared Fecal Calprotectin ELISA
ALPCO received 510(k) clearance from the US FDA for its new fecal Calprotectin Chemiluminescence ELISA test.
The ALPCO Calprotectin Chemiluminescence ELISA’s superior clinical accuracy will enable clinical laboratories to provide the most accurate results to gastroenterologists facing the cha...